![](/img/cover-not-exists.png)
Peroxisome proliferator–activated receptor-γ agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty
Guang Wang, Jinru Wei, Youfei Guan, Nan Jin, Jieming Mao, Xian WangVolume:
54
Year:
2005
Language:
english
DOI:
10.1016/j.metabol.2004.11.017
File:
PDF, 211 KB
english, 2005